An example of HeartFlow's new RoadMap Stenosis software that uses artificial intelligence (AI) to show areas of interest for possible stenting based on a patient's CT scan and FFR-CT. The software was rolled out commercially in April 2023.
Cardiology is linked to the second largest group of FDA-cleared clinical AI algorithms, and the number is still growing.
Image courtesy of Webb et al. and JACC: Cardiovascular Interventions.
A new-look TAVR valve was tested on patients for the first time, leading researchers to say its use appears to be "feasible and safe." More research, of course, is still required.
An example of HeartFlow's FFR-CT technology showing the coronary tree of a patient with a color-coded overlay showing critical drops in coronary blood flow. It takes the cardiac CT dataset and uses computational fluid dynamics to create virtual fraction flow reserve values. Photo by Dave Fornell
FFR-CT has grown in popularity due its ability to provide noninvasive evaluations of patients being considered for revascularization procedures. According to a new study in JACC: Cardiovascular Imaging, however, stress imaging strategies may still provide more value in certain scenarios.
